Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niggli

Showing results (441-450 of 516) with videos related to

Pageof 52
Sort By:
Haematologica|April 18, 2020
Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study groupOlga Moser, Martin Zimmermann, Ulrike Meyer, et al.
Pediatric Blood & Cancer|August 27, 2017
High-dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival-The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experienceRhoikos Furtwängler, Leo Kager, Patrick Melchior, et al.
Cancer Genetics and Cytogenetics|January 27, 2009
Non-classical karyotypic features in relapsed childhood B-cell precursor acute lymphoblastic leukemiaLea A Wehrli, Julia Braun, Luisa Nobile Buetti, et al.
Research and Practice in Thrombosis and Haemostasis|April 1, 2024
Long-term outcomes with emicizumab in hemophilia A without inhibitors: results from the HAVEN 3 and 4 studiesJohnny Mahlangu, Víctor Jiménez-Yuste, Giuliana Ventriglia, et al.
Pediatric Blood & Cancer|January 10, 2018
Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS)Monika Sparber-Sauer, Guido Seitz, Thekla von Kalle, et al.
Annals of Hematology|May 14, 2013
Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a "Watch and wait" strategy after complete resectionAndishe Attarbaschi, Auke Beishuizen, Georg Mann, et al.
Journal of the Royal Society, Interface|December 18, 2015
Impacts of feeding less food-competing feedstuffs to livestock on global food system sustainabilityChristian Schader, Adrian Muller, Nadia El-Hage Scialabba, et al.
Research and Practice in Thrombosis and Haemostasis|January 29, 2024
Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeksAnna Kiialainen, Joanne I Adamkewicz, Claire Petry, et al.
Blood|June 15, 2011
Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartmentMaike Schmitz, Petra Breithaupt, Nastassja Scheidegger, et al.
Cancer Immunology, Immunotherapy : CII|October 20, 2021
CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein-Barr virus genesSemjon Sidorov, Lara Fux, Katja Steiner, et al.
Pageof 52

Showing results (441-450 of 516) with videos related to

Sort By:
Pageof 52
Haematologica|April 18, 2020
Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study groupOlga Moser, Martin Zimmermann, Ulrike Meyer, et al.
Pediatric Blood & Cancer|August 27, 2017
High-dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival-The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experienceRhoikos Furtwängler, Leo Kager, Patrick Melchior, et al.
Cancer Genetics and Cytogenetics|January 27, 2009
Non-classical karyotypic features in relapsed childhood B-cell precursor acute lymphoblastic leukemiaLea A Wehrli, Julia Braun, Luisa Nobile Buetti, et al.
Research and Practice in Thrombosis and Haemostasis|April 1, 2024
Long-term outcomes with emicizumab in hemophilia A without inhibitors: results from the HAVEN 3 and 4 studiesJohnny Mahlangu, Víctor Jiménez-Yuste, Giuliana Ventriglia, et al.
Pediatric Blood & Cancer|January 10, 2018
Systemic therapy of aggressive fibromatosis in children and adolescents: Report of the Cooperative Weichteilsarkom Studiengruppe (CWS)Monika Sparber-Sauer, Guido Seitz, Thekla von Kalle, et al.
Annals of Hematology|May 14, 2013
Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a "Watch and wait" strategy after complete resectionAndishe Attarbaschi, Auke Beishuizen, Georg Mann, et al.
Journal of the Royal Society, Interface|December 18, 2015
Impacts of feeding less food-competing feedstuffs to livestock on global food system sustainabilityChristian Schader, Adrian Muller, Nadia El-Hage Scialabba, et al.
Research and Practice in Thrombosis and Haemostasis|January 29, 2024
Pharmacokinetics and coagulation biomarkers in children and adults with hemophilia A receiving emicizumab prophylaxis every 1, 2, or 4 weeksAnna Kiialainen, Joanne I Adamkewicz, Claire Petry, et al.
Blood|June 15, 2011
Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartmentMaike Schmitz, Petra Breithaupt, Nastassja Scheidegger, et al.
Cancer Immunology, Immunotherapy : CII|October 20, 2021
CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein-Barr virus genesSemjon Sidorov, Lara Fux, Katja Steiner, et al.
Pageof 52